A 60-year-old German man has become the seventh person worldwide potentially cured of HIV after a stem cell transplant in 2015.

Diagnosed with HIV in 2009, the patient underwent a bone marrow transplant for leukemia and has been in viral remission since 2018 without antiretroviral drugs.

Unlike previous cases, this patient received a stem cell transplant from a donor with only one copy of a mutated gene resistant to HIV.

This case challenges previous beliefs about HIV treatment and offers hope for future HIV cure strategies.

The findings will be presented at the International AIDS Conference in Munich, focusing on advancements and challenges in HIV cure research.

Significant progress has been made in HIV prevention, with lenacapavir found to be 100% effective in preventing HIV transmission in young women and girls.

Participants in the lenacapavir trial preferred long-acting injections over daily pills for HIV prevention.

A study using doxycycline showed an 80% reduction in STI infections in men who have sex with men.

Funding cuts threaten global HIV goals, emphasizing the need to address delivery and access concerns for these innovations to have a real-world impact.